Rush Cancer Center — Chicago, Illinois

Rush Cancer Center is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Rush Cancer Center has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Conventional Chondrosarcoma.

Sponsors: Exact Sciences Corporation, Inhibrx Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Cancer Center?

Rush Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Cancer Center conducted?

Rush Cancer Center has 2 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Conventional Chondrosarcoma.

Is Rush Cancer Center accredited by Crixeo Health?

Rush Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.